Brief: Acticor Biotech Launches Capital Increase Of Minimum Of EUR 7 Mln

Acticor Biotech SA

15/03/2024 06:37

March 15 (Reuters) -  ALACT.PA :
    * CAPITAL INCREASE ANNOUNCED ON THURSDAY
    * CONSISTING OF AN OFFER TO QUALIFIED INVESTORS, CATEGORIES
OF
INVESTORS AND INDIVIDUAL INVESTORS VIA THE PRIMARYBID PLATFORM
    * SUBSCRIPTION COMMITMENTS FROM EXISTING SHAREHOLDERS AND
NEW
INVESTORS FOR TOTAL OF AROUND EUR 6.46 MLN 
    * ISSUE PRICE OF NEW SHARES OF EUR 3.13 PER SHARE
    * FUNDS RAISED WILL BE USED PRINCIPALLY TO FINALIZE PHASE
2/3
STUDY ACTISAVE
    * FUNDS WILL ALSO BE USED FOR PREPARATION OF REGISTRATION
PLAN FOR
GLENZOCIMAB

        
 Source text: shorturl.at/txIS2
 Further company coverage:  ALACT.PA  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))